Blair William & Co
- SEC CIK
- 0000902367
- Latest filing
- Aug 11, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Blair William & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q2 2026)
- 356,032
- Value
- $32.2M
- % of portfolio
- 0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 356,032 | $32.2M | 0.1% | +40,342+12.8% | Added | Holders |
| Q1 2026 | 315,690 | $25.3M | 0.1% | −29,110−8.4% | Reduced | Holders |
| Q4 2025 | 344,800 | $29.4M | 0.1% | −27,553−7.4% | Reduced | Holders |
| Q3 2025 | 372,353 | $29.0M | 0.1% | −17,780−4.6% | Reduced | Holders |
| Q2 2025 | 390,133 | $30.5M | 0.1% | −30,093−7.2% | Reduced | Holders |
| Q1 2025 | 420,226 | $30.5M | 0.1% | −106,066−20.2% | Reduced | Holders |
| Q4 2024 | 526,292 | $39.0M | 0.1% | −77,310−12.8% | Reduced | Holders |
| Q3 2024 | 603,602 | $39.8M | 0.1% | −123,931−17.0% | Reduced | Holders |
| Q2 2024 | 727,533 | $67.2M | 0.2% | −193,243−21.0% | Reduced | Holders |
| Q1 2024 | 920,776 | $88.0M | 0.3% | −24,905−2.6% | Reduced | Holders |
| Q4 2023 | 945,681 | $72.1M | 0.2% | −59,594−5.9% | Reduced | Holders |
| Q3 2023 | 1,005,275 | $69.6M | 0.3% | −56,394−5.3% | Reduced | Holders |
| Q2 2023 | 1,061,669 | $100.1M | 0.4% | +32,547+3.2% | Added | Holders |
| Q1 2023 | 1,029,122 | $85.1M | 0.3% | −78,820−7.1% | Reduced | Holders |
| Q4 2022 | 1,107,942 | $82.7M | 0.4% | −33,739−3.0% | Reduced | Holders |
| Q3 2022 | 1,141,681 | $94.3M | 0.4% | +1890.0% | Added | Holders |
| Q2 2022 | 1,141,492 | $108.5M | 0.5% | +218,926+23.7% | Added | Holders |
| Q1 2022 | 922,566 | $108.6M | 0.4% | −22,902−2.4% | Reduced | Holders |
| Q4 2021 | 945,468 | $122.5M | 0.4% | +21,684+2.3% | Added | Holders |
| Q3 2021 | 923,784 | $104.6M | 0.4% | −629−0.1% | Reduced | Holders |
| Q2 2021 | 924,413 | $95.7M | 0.3% | +28,241+3.2% | Added | Holders |
| Q1 2021 | 896,172 | $75.0M | 0.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.